VAD Patients’ Recovery Facilitated By Steroid Treatment, Early Studies Show
This article was originally published in The Gray Sheet
Executive Summary
End-stage heart failure patients treated with left-ventricular assist devices and the drug clenbuterol may improve enough to warrant device explants, according to preliminary trial data presented at the Congress of the European Society of Cardiology in Berlin Sept. 4